Urokinase-type plasminogen activator receptor (uPAR) on tumor-associated macrophages is a marker of poor prognosis in colorectal cancer.

MLA

Illemann, Martin, et al. “Urokinase-Type Plasminogen Activator Receptor (UPAR) on Tumor-Associated Macrophages Is a Marker of Poor Prognosis in Colorectal Cancer.” Cancer Medicine, vol. 3, no. 4, Aug. 2014, pp. 855–64. EBSCOhost, https://doi.org/10.1002/cam4.242.

APA

Illemann, M., Laerum, O. D., Hasselby, J. P., Thurison, T., Høyer-Hansen, G., Nielsen, H. J., & Christensen, I. J. (2014). Urokinase-type plasminogen activator receptor (uPAR) on tumor-associated macrophages is a marker of poor prognosis in colorectal cancer. Cancer Medicine, 3(4), 855–864. https://doi.org/10.1002/cam4.242

Chicago

Illemann, Martin, Ole Didrik Laerum, Jane Preuss Hasselby, Tine Thurison, Gunilla Høyer-Hansen, Hans Jørgen Nielsen, and Ib Jarle Christensen. 2014. “Urokinase-Type Plasminogen Activator Receptor (UPAR) on Tumor-Associated Macrophages Is a Marker of Poor Prognosis in Colorectal Cancer.” Cancer Medicine 3 (4): 855–64. doi:10.1002/cam4.242.